Methodology for Flow Cytometric Analysis of Dendritic Cell Subsets in Pregnant Women with Early Onset Pre-eclampsia| Chapter 9 | New Advances in Medicine and Medical Science Vol. 2

 Pre-eclampsia (PE) is a supporting-inflammatory affliction associated with pregnancy. The only famous remedy is to give the fetus and amniotic sac. Hypertension and proteinuria after the 20th period of pregnancy are clinical signs of PE. Early onset pre-eclampsia (EOPE), a harsh variant of PE, is defined as dispassionate signs appearing before 34 weeks of gestation. Human dendritic cell (DC) subtypes (CD1c+, CD141+ myeloid Energized matter, and plasmacytoid DCs) are intricately involved in the inflammatory process and are significantly changed in a type of proinflammatory illnesses. These alterations provide profit for monitoring DC subsets as potential biomarker(s) and as aims for immunotherapeutic treatment. The main objective of the study search out delineate in what way or manner the three DC subsets are altered quantitatively and functionally in blood and decidua of EOPE subjects, compared to sane pregnant wives.DC subsets play an important role in common pregnancy by promoting effective trophoblast transfer and invasion and corroborating an anti-inflammatory environment of immunotolerance. In contrast, a detailed test of the makeup and function of DC subsets in the proinflammatory atmosphere of EOPE pregnancy is necessary. In this regard, the developed methods examines by means of what DC subsets differ (quantitatively and functionally) in EOPE subjects versus rational pregnant women. The multiparametric flow cytometry form is used to determine alterations in the description of DC subsets in the blood and decidua of EOPE subjects. Normal significant women are included as controls.Recognizing possible biomarkers will rest on an understanding of alterations in the profile of DC subsets in ancestry samples from EOPE patients. The basis for designing innovative immunotherapeutic methods targeting miscellaneous DC subsets or their products for the situation of EOPE will similarly be variations in the characterization of DC subsets in the decidua of EOPE patients. Overall, the methods will support the development of future big, prospective dispassionate trials with a devote effort to something developing approaches for the early discovery and treatment of EOPE in meaningful women.

Author(s) Details:

Aarthi Sundararajan,
Institute of Science, Nirma University, Ahmedabad, Gujarat-382481, India.

Rohit Jain,
GMERS Medical College and Civil Hospital, Gandhinagar, Gujarat-382007, India.

Kranti Vora,
Indian Institute of Public Health Gandhinagar, Lekawada, Gandhinagar, Gujarat-382042, India.

Senthilkumar Natesan,
Indian Institute of Public Health Gandhinagar, Lekawada, Gandhinagar, Gujarat-382042, India.

Vidhi Vaidya,
Institute of Science, Nirma University, Ahmedabad, Gujarat-382481, India.

Please see the link here: https://stm.bookpi.org/NAMMS-V2/article/view/10627

Relevance of Serum Tumour Necrosis Factor-Alpha Measurement in Acute Leukaemia | Chapter 1 | Perspective of Recent Advances in Medical Research Vol. 12

 Tumor loss determinant-alpha (TNF- α) is a pleiotropic cytokine that founds a favourable surroundings for diseased cells so they can fend off the invulnerable order, survive, and oppose situation. It has happened displayed that it is ectopically produced in the tumour microenvironment by leukemic and immunological containers, supporting a favourable atmosphere for the growth and growth of diseased containers. Considering the varied act and various verbalization pattern of TNF- α in acute leukemia and allure dispassionate pertinence, we monitored the level of TNF- α in severe leukemia cases and allure equating with ailment effect.Serum levels of TNF- α were calculated in 90 diagnosed cases of severe leukemia in addition to 10 controls utilizing a Diaclone Human ELISA kit (stable state grinder ELISA) at the time of disease and afterwards initiation chemotherapy to notice the effect of a destructive agent on TNF- α levels.At the time of disease, T-severe lymphoblastic leukaemia cases had significantly bigger TNF- α levels than the Control, understood by severe myeloid leukaemia and B-acute lymphoblastic leukaemia. A meaningful decline in antitoxin TNF- α level was seen in severe leukemia inmates later induction aspect a destructive agent (P<0.05). The levels were significantly reduced (P<0.001) nearly all of severe leukemia cases afterwards the inference phase, while extreme TNF- α levels were absolutely equated with wanting pause rank in the remaining cases.Acute leukaemia progresses and relapses on account of TNF- α. In cases accompanying acute leukaemia, extreme levels are guide leukocytosis, inflated blast numbers, and worse continuation. Monitoring of TNF- α can be advantageous in severe leukemia patients because free antagonistic -TNF- α therapy.

Author(s) Details:

Geeta Yadav,
Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh -226003, India.

U. S. Singh,
Department of Pathology, King George’s Medical University, Lucknow, Uttar Pradesh -226003, India.

Please see the link here: https://stm.bookpi.org/PRAMR-V12/article/view/9655

Complementary Role of Bone Marrow Aspiration and Biopsy: A Retrospective Study | Chapter 17 | Current Practice in Medical Science Vol. 1

The goal of the current study was to demonstrate the complimentary roles of both procedures by comparing the outcomes of bone marrow aspiration (BMA) and bone marrow trephine biopsies (BMB). A bone marrow inquiry is necessary for the assessment of various haematological and non-hematological diseases. The two most often used procedures for diagnosis are bone marrow aspiration and bone marrow biopsy, and both work best when done at the same time. This retrospective study examined 74 cases of bone marrow examinations that were received by our institution's pathology department from January 2019 to August 2020. Giemsa and iron stain were used to stain all aspirations, whereas normal H&E stain was used to stain all biopsy samples. IHC markers and reticulin dye were applied as needed. In cases of diverse haematological and non-hematological diagnoses, a bone marrow investigation is crucial. The aspirated smear is primarily used for cytologic details while the biopsy sections are primarily useful for cellularity, fibrosis, architectural pattern, metastatic deposits, and from the same tissue we can go for Immunohistochemistry. Bone marrow aspiration and biopsy using standard staining procedures, fixation, embedding, and cutting techniques, generally complement each other. As this is a relatively difficult invasive operation, appropriate technique should be kept in mind when doing BMA and BMB concurrently to maximise material yield and decrease patient discomfort by avoiding repeating the procedure owing to inadequate material.

Author(s) Details:

Nirali Shah,

Medical College, Baroda, Gujarat, India.

Vidhi Shah,

Medical College, Baroda, Gujarat, India.

Falguni Goswami,

Medical College, Baroda, Gujarat, India.

Roopam Gidwani,

Medical College, Baroda, Gujarat, India.

Please see the link here: https://stm.bookpi.org/CPMS-V1/article/view/7336

Determination of Lymphoma without Peripheral Lymphadenopathy: An Approach to Definitive Diagnosis by Flowcytometry | Chapter 16 | Issues and Developments in Medicine and Medical Research Vol. 6

 The indolent B-cell neoplasm splenic lymphoma with circulating villous lymphocytes (SLVL) is a splenic lymphoma with circulating villous lymphocytes. Due to its rarity, determining a clear diagnosis might be difficult. The most common kind of lymphoma linked to HCV infection is marginal zone lymphoma. We will examine SLVL in this study through a variety of ways. Peripheral lymphadenopathy is not seen in these patients, despite the fact that it is a lymphoma variation. Flow-cytometry analysis of a blood or bone marrow sample may be helpful in determining the proper diagnosis.

Author(S) Details

Amar Ranjan
Laboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.

Harshita Dubey
Laboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.

Raja Pramanik
Laboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.

Divya Sethi
Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.

Pranay Tanwar
Laboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.

Lawanya Ranjan
Monash College, Melbourne, Australia.

S. H. Chandrashekhara
Department of Radiodiagnosis, IRCH, All India Institute of Medical Sciences, Delhi, India.

Meenakshi Wadhwani
Laboratory Oncology Unit, All India Institute of Medical Sciences, New Delhi, India.

View Book:- https://stm.bookpi.org/IDMMR-V6/article/view/5609

Role of PKC in CD47-Mediated Phosphatidylserine Expression Pathway in Jurkat T Cells: A Preliminary Study | Chapter 10 | Current Aspects in Pharmaceutical Research and Development Vol. 2

 T-cell acute lymphoblastic leukaemia (T-ALL) treatment failure occurs when leukemic blasts develop resistance to chemotherapeutic drugs. The hunt for targets for the creation of more effective and less toxic anti-leukemic medicines is now underway. CD47 has been linked to chemo-resistance and cancer cell metastasis. Although numerous possible pathways have been proposed to explain the therapeutic impact of CD47-targeting, the downstream effectors that contribute to varied CD47 effects are yet unknown. We investigated the involvement of Protein Kinase C (PKC) in the CD47-mediated phosphatidylserine expression pathway in Jurkat T cells in this early work. In the presence or absence of Bisindolylmaleimide I, hydrochloride, Jurkat T cells were incubated with anti-CD47 mAb (BRIC 126), anti-CD44 mAb (BRIC 235), or control (PKC inhibitor). Annexin-V FITC was used to label the cells. Fluorescence intensity was measured using flow cytometry analysis. The trypan blue exclusion test was used to determine cell viability. In the CD47 receptor mediated leukaemia cells apoptotic pathway, inhibiting PKC increased phosphatidylserine expression. This suggests that PKC is involved in the PS exposure route in jurkat T cells mediated by CD47. CD47 and PKC were discovered to be novel functional proteins in jurkat T cells with intriguing therapeutic potential, according to the findings of this study. This research could lead to new approaches to treating T-ALL illness.

Author(s) Details

Ikenna Kingsley Uchendu
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Ogbonna Kosisochukwu Doris
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Oguji Cyprian Emeka
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Omeh Johnson Obiechina
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Ochi John Chidubem
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Udeh Abel Chukwuebuka
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Obigeorge Chibueze Joseph
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Chinecherem Maudlyne Nnam
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

Olatunji Omokungbe
Department of Medical Laboratory Science, University of Nigeria, Enugu Campus, Enugu State, Nigeria.

View Book :- https://stm.bookpi.org/CAPRD-V2/article/view/3958

Bone Marrow Involvement in Non-Small Cell Lung Cancer | Chapter 7 | Highlights on Medicine and Medical Science Vol. 17

 Disseminated tumour cells (DTCs) in the bone marrow (BM) have been found to be distant metastasis progenitors. The finding of DTCs in non-small cell lung cancer (NSCLC) will provide critical information on metastatic characteristics, as well as the possibility of uncovering new targets for NSCLC treatment. The study's purpose is to examine if DTC can be found in BM and to figure out how often BM involvement is in NSCLC patients, as well as how it affects the lymphocyte population in the BM. 62 bone marrow samples from NSCLC patients were examined using morphological and immunological methods. Flow cytometry (FACS Canto II, USA, Kaluza Analysis v2.1 software) was used to analyse DTCs. Monoclonal antibodies to CD45, EPCAM, CD133, lymphocyte populations CD3, CD4, CD8, CD19, CD20, CD16, and CD27 were directly labelled with various fluorochromes. In 43.5 percent of patients, EPCAM+CD45- (DTCs) were identified in the BM (threshold level: 1 cell per 10 million myelocaricytes). In 33.3% (9/27) of the instances, CD133+EPCAM+CD45-cells were discovered. DTC presence had no correlation with tumour size, lymph node status, or tumour stage. Stages IA and IIA had the highest rates of DTC detection: 60.7 percent and 58.3 percent, respectively. BM involvement was observed in 45 percent of instances of adenocarcinoma and 37 percent of samples of squamous cell carcinoma (p = 0.501). Highly differentiated tumours had a higher prevalence of DTCs (p = 0.023). There are no significant links between the presence of DTCs in the BM and the parameters of the myelogram. In 4 percent of BM involvement, the number of granulocytic lineage cells decreased (p = 0.036). With BM injury, the level of CD16 + CD4-NK-cells (p = 0.002) and CD27 + CD3 + T-cells (p = 0.015) subpopulations increased significantly. DTCs can be found in the BM of NSCLC patients, according to the findings. The BM accounted for 43.5 percent of the participants. DTCs are observed even in the early stages of NSCLC. A relationship between BM involvement and the degree of tumour differentiation was established. Squamous cell lung cancer exhibited a higher rate of BM involvement than adenocarcinoma of the lung. The link between DTCs and BM lymphocyte populations was discovered: CD16 + CD4-, CD27 + CD3+ subpopulations.

Author (S) Details

Stilidi Ivan
Federal State Budgetary Institute “N.N. Blokhin National medical research center of oncology” of the Russian Ministry of Health, Moscow; Kashyrskoe sh.24, Moscow, 115478, Russia and Pirogov N.I. Russian National Research Medical University of the Russian Ministry of Health, 1, Ostrovitianova st., Moscow, 117997, Russia.

Kononetz Pavel
Federal State Budgetary Institute “N.N. Blokhin National medical research center of oncology” of the Russian Ministry of Health, Moscow; Kashyrskoe sh.24, Moscow, 115478, Russia.

Chulkova Svetlana
Federal State Budgetary Institute “N.N. Blokhin National medical research center of oncology” of the Russian Ministry of Health, Moscow; Kashyrskoe sh.24, Moscow, 115478, Russia and Pirogov N.I. Russian National Research Medical University of the Russian Ministry of Health, 1, Ostrovitianova st., Moscow, 117997, Russia.

Tupitsyn Nikolay
Federal State Budgetary Institute “N.N. Blokhin National medical research center of oncology” of the Russian Ministry of Health, Moscow; Kashyrskoe sh.24, Moscow, 115478, Russia.

View Book :- https://stm.bookpi.org/HMMS-V17/article/view/2610

Optimizing in vitro Generation of Interleukin-10 Secreting B Regulatory Cells | Chapter 1 | Recent Research Advances in Biology Vol. 10

 Bregulatory cells are a subpopulation of IL-10-secreting B-cells that are frequently identified as CD19+/38hi/24hi (B-regs). Changes in stimulating molecule concentration have an influence on the population of human Interleukin-10 secreting B-regs. For possible cell treatment, B-regs can be generated by in-vitro co-culture of adipose tissue derived mesenchymal stromal cells (AD-MSC) and peripheral blood mononuclear cells (PBMC). In the co-culture of AD-MSC and peripheral blood mononuclear cells (LPS-EK), lipopolysaccharide–E.coli–K12 strain (LPS-EK) was added in various doses. cellular (PBMC). The concentration of IL-10 in the cell supernatant was measured using a quantitative ELISA at each time point. Cells were examined for morphology, sterility, total count, vitality, and immune-phenotype. The data was evaluated to establish the time interval during which the greatest B-reg population and IL-10 secretion were achieved. The current study adds to our understanding of the kinetics of IL-10 secretion by human B-regs derived from AD-MSC and PBMC in vitro. The current research focuses on the in vitro production of B-regs from mesenchymal stem cells generated from adipose tissue. stromal cells (AD-MSC) and peripheral blood mononuclear cells (PBMC), as well as a partial characterisation of B-regs in terms of IL-10 secretion, time, and the quantity of stimulating molecule (i.e. LPS-EK) required for optimal IL-10 secretion. B-regs have been found to secrete cytokine in trace amounts. The media used to feed the cells dilutes the released cytokines by several orders of magnitude. The samples in our investigation were properly concentrated so that the cytokines could be detected using a quantitative Enzyme Linked Immunosorbent Assay (ELISA).

Author (s) Details

K. S. Gupte
Department of Cell Therapy and Regenerative Medicine. G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), India.

A. V. Vanikar
Department of Cell Therapy and Regenerative Medicine. G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), India and Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology. G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & ResearchCentre (IKDRC) - Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS),India.

C. N. Patel
Department of Cell Therapy and Regenerative Medicine. G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), India.

U. G. Thakkar
Department of Cell Therapy and Regenerative Medicine. G.R. Doshi and K.M. Mehta Institute of Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi Institute of Transplantation Sciences (ITS), India.

View Book :- https://stm.bookpi.org/RRAB-V10/article/view/2131